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The peripheral terminals of primary nociceptive neu-
rons play an essential role in pain detection medi-
ated bymembrane receptors like TRPV1, amolecular
sensor of heat and capsaicin. However, the contri-
bution of central terminal TRPV1 in the dorsal
horn to chronic pain has not been investigated
directly. Combining primary sensory neuron-specific
GCaMP3 imaging with a trigeminal neuropathic pain
model, we detected robust neuronal hyperactivity in
injured and uninjured nerves in the skin, soma in tri-
geminal ganglion, and central terminals in the spinal
trigeminal nucleus. Extensive TRPV1 hyperactivity
was observed in central terminals innervating all
dorsal horn laminae. The central terminal TRPV1
sensitization was maintained by descending seroto-
nergic (5-HT) input from the brainstem. Central
blockade of TRPV1 or 5-HT/5-HT3A receptors atten-
uated central terminal sensitization, excitatory pri-
mary afferent inputs, and mechanical hyperalgesia
in the territories of injured and uninjured nerves. Our
results reveal central mechanisms facilitating central
terminal sensitization underlying chronic pain.
INTRODUCTION
Small-diameter nociceptive neurons whose cell bodies reside in
dorsal root ganglia (DRG) and trigeminal ganglia (TG) play essen-
tial roles in pain signal detection, transmission, and modulation
(Basbaum et al., 2009). The peripheral axons of these pseudou-
nipolar neurons innervate tissues, such as skin, muscle, and
visceral organs, to detect painful stimuli, whereas their central
axons transmit these signals to secondary-order neurons in the
spinal cord dorsal horn (in the case of DRG neurons) and theanalogous trigeminal subnucleus caudalis (Vc, in the case of
TG neurons). Peripheral tissue and nerve injury can lead to
hyperalgesia, a state in which painful stimuli are perceived as
more painful than normal. One major contributor to hyperalgesia
is augmented sensitivity of primary nociceptive neurons, a phe-
nomenon called peripheral sensitization (Treede et al., 1992).
Although sensitization of peripheral terminals can be readily
detected by sensory nerve recordings in the skin-nerve prepara-
tion, technical barriers have limited investigation of the role of
the central terminals of primary sensory neurons in sensitization
and hyperalgesia.
TRPV1, a nonselective cation channel, is a key molecular
component of pain detection and modulation (Caterina et al.,
1997, 2000). Although TRPV1 protein is present throughout
many nociceptive neurons (i.e., along peripheral and central
axons) (Caterina et al., 2000; Guo et al., 1999), previous studies
have mainly focused on its function as a molecular sensor of
noxious heat and capsaicin in the peripheral terminals. Hyperal-
gesia resulting from tissue injury or inflammation is often associ-
ated with sensitization of TRPV1 channel activity that can occur
through several mechanisms, such as phosphorylation, inter-
action with phospholipid PIP2, trafficking, and association
with accessory proteins (Bhave et al., 2002; Lukacs et al.,
2007; Zhang et al., 2005, 2008). Recent studies have implicated
TRPV1 in the modulation of sensory transmission from the cen-
tral terminals of primary afferents to spinal dorsal horn neurons
(Gregus et al., 2012; Sikand and Premkumar, 2007; Tognetto
et al., 2001; Yang et al., 1998). However, an understanding of
the mechanisms by which TRPV1 or other molecules contribute
to central terminal sensitization events underlying persistent
pain will require approaches that allow one to directly monitor
presynaptic neuronal activity and its hyperactivity.
We combined primary sensory neuron-specific GCaMP3
imaging with a trigeminal neuropathic pain model and detected
robust neuronal hypersensitivity in injured and uninjured nerves
in the skin, soma in trigeminal ganglion, and central terminals in
the spinal trigeminal nucleus. Strikingly, extensive TRPV1 hyper-
activity was observed in central terminals innervating all dorsalNeuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 873
Figure 1. Trigeminal CCI-ION in Pirt-GCaMP3 Mice Shows Long-
Lasting Hyperalgesia from Territories Innervated by Injured and
Uninjured Nerves
(A) The CCI-ION and the anatomy in orofacial and trigeminal system are
shown.
(B) Mechanical hyperalgesia was tested at the ipsilateral V2 whisker pad
(injured), the V3 lower jaw (uninjured), and contralateral V2 regions at 5, 14, and
28 days after CCI-ION (n = 8) or sham (n = 6) inmice. The data are expressed as
an EF50 value and are presented as mean ± SEM.
(C and D) Cheek injection of capsaicin evokes nocifensive facial wiping by the
forepaw. The number of face wipes were measured within 30 min of capsaicin
(0.5 mg) injection into the cheek (V2, injured) and the anterior part of ear skin
(V3, uninjured; n = 10 for each group). Data are presented as mean ± SEM.
**p < 0.01; ***p < 0.001 versus baseline (B) or sham (C and D).
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Mechanism of Central Terminal TRPV1 Sensitizationhorn laminae. Thecentral terminal TRPV1sensitizationwasmain-
tained by upregulated descending serotonergic (5-HT) input from
the rostral ventromedial medulla (RVM) in the brainstem. Central
blockade of TRPV1 or 5-HT/5-HT3A receptor attenuated TRPV1-
dependent central terminal sensitization, excitatory primary
afferent inputs, and mechanical hyperalgesia in the territories
of injured and uninjured nerves. Therefore, our results reveal a874 Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc.pain mechanism in which descending 5-HT from the RVM main-
tains central terminal sensitization by activation of presynaptic
5-HT3A receptors and subsequent facilitation of TRPV1 activity.
RESULTS
Generation and Initial Characterization of Pirt-GCaMP3
Mice
Todevelop abettermeans of specificallymonitoringprimary sen-
sory neuron activity, we generated a knockin mouse line in which
GCaMP3 expression is driven by the Pirt promoter. GCaMP3 is a
genetically encoded calcium indicator whose green fluorescent
intensity is dramatically increased after binding to intracellular
Ca2+ and that has been used to effectively visualize neuronal ac-
tivity in several animal models (Tian et al., 2009). The Pirt pro-
moter is a strong and selective pan-DRG and TG promoter that
is expressed in almost all primary sensory neurons (Figure S1A
available online) but that is not expressed in glia, in other periph-
eral tissues, such as skin and muscle, or in the CNS (Kim et al.,
2008). We compared Ca2+ imaging assays using conventional
Fura2dye loadingof cultureddissociatedwild-typeDRGneurons
and Pirt-GCaMP3 transgenic DRG neurons (Figure S2A). When
treated with a high level of KCl (100 mM), both methods revealed
activationof87%of totalDRGneurons,which is consistentwith
Pirt-GCaMP3 being present in almost all DRG neurons.
Developing aMouse Trigeminal Neuropathic PainModel
Because of its unique anatomical characteristics and clinical
relevance, the trigeminal system has been used to study persis-
tent or chronic pain. The trigeminal nerve originates from TG,
which divides into three large branches: the ophthalmic (V1),
maxillary (V2), and mandibular (V3), each of which innervate a
distinct orofacial region (Figure 1A). To study peripheral and cen-
tral mechanisms of neuropathic pain using Pirt-GCaMP3 mice,
we adapted our rat model of chronic constriction injury of the in-
fraorbital nerve (CCI-ION), the major branch of V2 (Klein et al.,
1988), to mice (Figure 1A) (Okubo et al., 2013; Wei et al., 2008).
For assessing mechanical hyperalgesia, von Frey filaments
were applied to the whisker pad (injured V2 territory) or lower
jaw (uninjured V3 territory) area. An active withdrawal of the
head from the probing filament was defined as a nocifensive
response (Movies S1 and S2). The mechanical pain threshold
was quantified as EF50, the mechanical force that produced a
50% response frequency. Compared with the sham group and
baseline, CCI-treated animals exhibited significant decreases
in EF50s (i.e., lower mechanical pain threshold) of both ipsilateral
V2 and V3 regions measured at 5, 14, and 28 days after surgery
(Figure 1B). There was no significant change in the mechanical
pain threshold of the contralateral V2 after CCI-ION (Figure 1B).
Therefore, CCI-ION mice showed long-lasting mechanical
hyperalgesia in territories innervated by injured and uninjured
nerves. In addition, capsaicin-evoked nocifensive responses
were also significantly increased in both ipsilateral V2 and V3
regions 14 days after CCI-ION compared to the sham group (Fig-
ures 1C and 1D). These results indicate that the mouse CCI-ION
model exhibits primary hyperalgesia in the V2 skin, which is
innervated by the injured ION, as well as a spread of hyper-
algesia to the V3 area innervated by the uninjured V3 nerve.
Figure 2. Ear Skin Nerve Fibers in the
Secondary Hyperalgesia Region Show
Peripheral Hypersensitivity after CCI-ION
in Pirt-GCaMP3 Mice
(A) Schematic diagram of amouse ear. Red or blue
color indicates where V3 nerve fibers (green) or C2
nerve fibers are innervated into ear skin, respec-
tively. White square dash lines indicate where the
image was taken.
(B) Representative GCaMP3 imaging of ear skin
explants. Ear skin after CCI-ION in Pirt-GCaMP3
mice were activated by capsaicin (1 mM) or high
KCl (100 mM). Upper rows show ipsilateral (on the
CCI-ION side) V3 region. Middle rows show
contralateral (uninjured side) V3 region. Lower
rows show ipsilateral C2 region. Yellow arrow-
heads indicate hairs and hair follicles that are au-
tofluoresecent. Red arrowheads indicate activated
fibers and endings. Ipsi., ipsilateral; cont., contra-
lateral. Scale bar, 50 mm.
(C–E) In left panels time course of the amplitude
of the Ca2+ transient that was evoked by 1 mM
capsaicin (C), 10 mM capsaicin (D), or 100 mM
KCl (E) application in ear skin. In right panels
Ca2+ transient amounts with area under curve
(AUC) that was evoked by 1 mM capsaicin (C),
10 mM capsaicin (D), or 100 mM KCl (E) in ear
skin. All population data for Ca2+ transient are
expressed as the percentage of baseline Ca2+
transient (DF/F0) and are presented as mean ±
SEM. Black bars indicate when stimuli were
applied.
(F) Length of ear skin fibers and endings after activation by capsaicin (1 and 10 mM), which was normalized to the length activated by KCl. Significant increases
were found in ipsilateral ear (V3) as compared to contralateral ear (V3) or ipsilateral ear (C2). *p < 0.05; **p < 0.01; ***p < 0.001.
Data are presented as mean ± SEM.
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Mechanism of Central Terminal TRPV1 SensitizationExtraterritorial hyperalgesia, i.e., the hyperalgesia found within
the V3 skin, is a prominent component of many clinical chronic
pain conditions and is thought to be related to CNSmechanisms
(Ringkamp and Meyer, 2005).
Terminals of Uninjured Nerves in the Skin Became
Hypersensitized
We next used the CCI-ION model, in combination with Pirt-
GCaMP3 imaging, to determine whether uninjured primary affer-
ents are involved in extraterritorial hyperalgesia. We primarily
used capsaicin to probe neuronal hypersensitivity because the
dosage of capsaicin application can be quantitatively controlled.
The complete absence of Ca2+ signals evoked by capsaicin in
Pirt-GCaMP3;TRPV1/ mice confirmed that capsaicin could
be used to specifically monitor TRPV1 activity (Figure S2B).
Importantly, we also determined that CCI-ION did not change
GCaMP3 protein levels in the TG of Pirt-GCaMP3 mice (Figures
S1B and S1C). Because GCaMP3 was expressed in nearly all
neurons in the DRG and TG of Pirt-GCaMP3mice and its expres-
sion levels remained constant after nerve injury, Pirt-GCaMP3
mice provided a suitable tool to monitor plasticity of primary sen-
sory neurons under neuropathic pain conditions.
To examine whether neuronal activity of uninjured V3 nerves
was affected by CCI-ION, we imaged peripheral nerve fiber
and terminal activation in acutely isolated hairy ear skin explants
from Pirt-GCaMP3 mice, 10–17 days after CCI-ION. Figure 2Ashows a schematic diagram of a mouse ear and the location at
which images were taken in the V3 and C2 regions of ear skin.
The anterior ear skin receptive field is innervated by the V3 nerve,
similar to the lower jaw, but the former is better separated from
the whisker pad. The posterior part of the ear skin is innervated
by the cervical C2 DRG fibers (Figure 2A) (Neubert et al., 2005).
To confirm the V3 innervation of the external ear, the retrograde
nerve tracer DiI was injected into the skin over the anterior upper
part of the external ear. DiI-labeled neurons were located in the
V3, but not in the V1 or V2, division of the TG (Figure S3A). In
contrast, DiI injection into the whisker pad (V2) only labeled
neurons in V2, but not in V3, division of the TG (Figure S3B).
The basal GCaMP3 fluorescence level is very low in nerve
fibers in the ear skin without any stimulation. Ear explants were
perfused with capsaicin and washed and then treated again
with a high level of KCl (100 mM). Interestingly, capsaicin appli-
cation evoked robust and stronger Ca2+ responses in multiple
nerve fibers of the anterior part of ipsilateral ear skin (V3)
following CCI-ION when compared to Ca2+ responses in the
contralateral ear skin (V3) and the posterior part of the ipsilateral
ear skin (C2) (Figure 2B; Movies S3 and S4). The capsaicin-
induced Ca2+ response was dose-dependent and reversible
(Figures 2B–2D). At 1 mM capsaicin application, the peak ampli-
tude of the absolute Ca2+ transient (DF/F0) in ipsilateral V3 (0.09 ±
0.03) was significantly greater than that of contralateral V3
(0.02 ± 0.00; n = 10 explants per group) or that of ipsilateral C2Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 875
Figure 3. TG Neurons Show Neuronal Hyperactivity after CCI-ION in Pirt-GCaMP3 Mice
(A) Schematic diagram of a mouse TG. Black dash lines indicate the border of three large divisions (V1, V2, and V3) in TG (green cells). White square dash lines
indicate where the image was taken.
(B andC) Representative GCaMP3 imaging of TG explants. TG neurons of V2 (B) or V3 (C) division after CCI-ION inPirt-GCaMP3micewere activated by capsaicin
(1 mM) or KCl (100 mM). Upper panels show ipsilateral V2 (B) or V3 (C) division of TG. Lower panels show contralateral V2 (B) or V3 (C) division of TG. Scale bar,
50 mm for both. Arrowheads in red indicate TG neurons that are over 30 mm diameter and activated by capsaicin.
(D and E) Population data for V2 shown in (D) or for V3 shown in (E) are expressed as the percentage of KCl-sensitive TG neurons and are presented as mean ±
SEM. ipsi., ipsilateral; cont., contralateral. *p < 0.05; **p < 0.01; ***p < 0.001.
Data are presented as mean ± SEM.
Neuron
Mechanism of Central Terminal TRPV1 Sensitization(0.01 ± 0.01; n = 3, p < 0.05). We also performed area under
the curve (AUC) measurements of the integrated Ca2+ elevation
evoked by applied stimuli (Figure 2C). AUC (1 mM capsaicin)
in ipsilateral V3 (1.14 ± 0.15) was significantly larger than that
of contralateral V3 (0.32 ± 0.04; n = 10 for each group; p <
0.001) or ipsilateral C2 (0.48 ± 0.08; n = 3, p < 0.05). Similar re-
sults were obtainedwith 10 mMcapsaicin application (Figure 2D).
A high level of KCl activated a much larger population of
afferent fibers than capsaicin did, but neither the peak amplitude
nor integrated area of the KCl-evoked Ca2+ transient differ
between the three groups (ipsilateral V3, contralateral V3, and
ipsilateral C2) (Figure 2E). This is consistent with the finding
that GCaMP3 levels are the same between ipsilateral and contra-
lateral TG after CCI-ION (Figures S1B and S1C).
Besides comparing Ca2+ signal levels, we also examined
changes in the cumulative length of nerve fibers activated by
capsaicin after CCI-ION. These measurements were normalized
to the total length of fibers activated by high KCl and were876 Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc.expressed as a percentage of activated fiber length (Figure 2F).
Following capsaicin application, the cumulative activated fiber
length in ipsilateral V3 was significantly longer than that in
contralateral V3 (n = 10 per group, p < 0.001) or ipsilateral C2
(n = 3, p < 0.05; Figure 2F). Together, these data clearly indicate
that hyperactivity occurs in the nerve fibers in the skin innervated
by a neighboring uninjured nerve branches after CCI-ION.
RobustHyperactivity inMultipleCell Types in Trigeminal
Ganglion after CCI-ION
To evaluate neuronal activity in TG somata, we next imaged Ca2+
response in acutely isolated TG explants from Pirt-GCaMP3
mice. An advantage of visualizing TG explants is that neuronal
cell bodies in TG retain their somatotopic organization and
segregation (Figure 3A). The percentage of neurons that
responded to 1 mM capsaicin was significantly increased in
CCI-ION-injured ipsilateral V2 (22.55% ± 1.84%; normalized
by 100 mM KCl activation) compared with the uninjured
Neuron
Mechanism of Central Terminal TRPV1 Sensitizationcontralateral V2 TG (12.12%± 1.07%, p < 0.001, n = 12 explants)
(Figures 3B and 3D). However, at 10 mM capsaicin, there was no
significant difference between the injured and uninjured V2 TG
(Figure 3D; Movies S5 and S6). Similar to the V2 region, the per-
centage of neurons in the CCI-ION ipsilateral V3 (26.91% ±
1.05%) responding to 1 mMcapsaicin was significantly increased
compared to the contralateral V3 TG (14.30%± 2.72%, n = 4, p <
0.01), but at 10 mM capsaicin, no significant difference was
observed between the ipsilateral and contralateral V3 TG fol-
lowing CCI-ION (Figures 3C and 3E). Sham-operated animals
did not show any difference between the ipsilalateral and contra-
lateral V2 and V3 of TG (n = 3, p > 0.10, data not shown). Interest-
ingly, more of the capsaicin-sensitive (1 mM) neurons in the V2
area of the ipsilateral TG (8.46% ± 2.66%, p < 0.05) had large
diameter cell bodies (>30 mm) when compared to the capsa-
icin-sensitive neurons in the V2 of the contralateral TG (2.1% ±
0.83%, n = 12) (Figure 3D). In contrast, no increased activation
of large diameter cell bodies was found in V3 regions from the
ipsilateral compared with the contralateral TG (Figure 3E).
TRPV1 and Neuronal Hyperactivity in Central Terminals
Innervating All Dorsal Horn Lamina
To examine the contribution of central fibers and terminals of
primary sensory neurons to persistent pain, we next imaged
the activation of central projecting axons and terminals of TG
neurons in acute Vc slices from Pirt-GCaMP3 mice after CCI-
ION. The segregation of trigeminal branches is also maintained
in the central projection to Vc. V3, V2, and V1 axons terminate
in the dorsomedial, middle, and ventrolateral regions of Vc,
respectively (Nakajima et al., 2011; Rexed, 1952) (Figure 4A).
This unique feature of the TG system allowed us to image spe-
cific Vc subdivisions in which sensory signals are received and
transmitted from injured and uninjured peripheral axons. In addi-
tion, incoming C-fibers terminate in laminae I and II, whereas
A-fibers end predominately in lamina layers III and IV such that
neuronal activities of different sensory fiber subtypes can be
monitored accordingly (Mosconi et al., 2010). Figure 4A shows
the laminar organization of V2 and V3 in Vc andwhere the images
were analyzed. The Vc area was sliced using conventional vibra-
tome slicing methods. The fluorescence intensity of a subset
of sensory endings in superficial laminae was increased after
capsaicin treatment (Figures 4B and 4C; Movies S7 and S8).
Besides capsaicin, we also used low KCl (20 mM) to examine
overall neuronal excitability. Indeed, 20 mM KCl application
evoked the activation of sensory endings in the superficial dorsal
horn (C-fibers) as well as in deeper laminae (A-fibers) (Figures 4B
and 4C). The GCaMP3-mediated Ca2+ signal intensity evoked by
1 mM capsaicin was significantly increased in the ipsilateral V2
and V3 (n = 16, p < 0.01; n = 17, p < 0.01, respectively) in the
Vc slice from CCI-ION mice compared with that of the contralat-
eral side (n = 16, n = 17 slices, respectively). The significant
increase of activity in the ipsilateral V2 and V3 was found in all
laminae (I/IIo, IIi, III/IV; Figure 4D). Similar results were obtained
with 10 mM capsaicin (Figure 4E). In addition, more activated
nerve terminals were seen in the ipsilateral deeper laminae
(those innervated by larger diameter A-fibers) of the injured side.
Low KCl showed dramatically significant increases in activity
in the CCI-ION ipsilateral V2 and V3 (n = 16, p < 0.01 for both)of the Vc in all lamina (Figure 4F) compared with the contralateral
side (n = 16 for both). Responsiveness to high KCl (100 mM) was
not significantly different between the ipsilateral and contralat-
eral V2 and V3 (n = 17, p > 0.10; n = 18, p > 0.10, respectively)
(Figure 4G), suggesting that GCaMP3 protein levels at the central
terminals were unchanged after CCI-ION. These data demon-
strate the development of extensive hypersensitivity to capsaicin
and low KCl in the central terminals of both injured and neigh-
boring uninjured neurons following CCI-ION.
Descending 5-HT from RVM Is Upregulated after Nerve
Injury and Essential for Neuropathic Pain
The RVM in the brain stem is an important component of de-
scending modulatory systems that project to the spinal dorsal
horn and Vc and is involved in facilitatory and inhibitory modu-
lation of nociceptive inputs (Mason, 2001; Ren and Dubner,
2002). We and others have shown that 5-HT-dependent de-
scending facilitation from the RVM is involved in persistent hy-
peralgesia after injury (Okubo et al., 2013; Suzuki et al., 2004;
Wei et al., 2010). The robust hypersensitivity in central terminals
of uninjured primary sensory neurons throughout multiple
laminae of the V3 division of Vc after CCI-ION suggests a
possible CNS mechanism underlying the sensitization of these
central terminals. Here, we investigated by immunostaining
whether nerve injury causes any change in descending 5-HT-
positive fibers in the Vc sections (Figure 5A). Indeed, 14 days
after CCI-ION, there was a dramatic increase in 5-HT immuno-
reactivity in the ipsilateral Vc compared with the Vc from sham
animals or the contralateral side (Figure 5B). Importantly, the
descending 5-HT-positive fibers were in close vicinity to the
central terminals of primary sensory neurons stained with
GCaMP3 (Figure S4A). This is consistent with a previous study
showing that descending 5-HT-positive fibers form axoaxonic
contacts onto the central terminals of primary sensory neurons
(LaMotte and de Lanerolle, 1983).
Local gene transfer of a plasmid encoding a small hairpin RNA
(shRNA) targeting neuronal tryptophan hydroxylase-2 (Tph-2), a
key enzyme in the synthesis of 5-HT (Invernizzi, 2007), into the
RVM led to a significant reduction of 5-HT immunostaining in
the Vc, confirming the specificity of the staining and the origin
of the positive fibers (Figures 5C and S4B).
To determine the contribution of descending 5-HT to the sensi-
tization of primary afferent central terminals in Vc after nerve
injury, we imaged Vc slices obtained from CCI-ION-treated Pirt-
GCaMP3 mice whose RVMs were treated with either Tph-2
shRNA or scrambled shRNA. Strikingly, TRPV1 hyperactivity in
the central terminals in Vc was almost completely blocked by
depletion of 5-HT from the RVM, but not by scrambled shRNA
(Figures 5D and 5E; Figures S5A, S5B, and S5D). This inhibitory
effect of intra-RVM treatment of Tph-2 shRNA on TRPV1 hyper-
sensitivity could be seen in laminae I to IV of both V2 (injured)
and V3 (uninjured) subdivisions of the Vc. In addition, overall
neuronal hyperactivity of central terminals to low KCl (20 mM)
was also significantly suppressed by Tph-2 shRNA as compared
to scrambled shRNA (Figures 5D and 5F; Figures S5A and S5C).
In contrast, depletion of 5-HT in theRVMhadnodetectable effect
on central terminal responsiveness to a stronger depolarizing
stimulus, high KCl (100 mM) (Figure S5E). Similar descendingNeuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 877
Figure 4. Central Nerve Fibers and Terminals of Vc in TG System Show Strong Central Terminal Hypersensitivity after CCI-ION in
Pirt-GCaMP3 Mice
(A) Schematic diagram of a mouse Vc. Black dash lines indicate the border of three large divisions (V1, V2, and V3) in Vc. White square dash lines indicate where
the region of the nerve fibers and terminals (green) was selected and analyzed to measure Ca2+ transient at different lamina (yellow dash lines).
(B and C) Representative GCaMP3 imaging of Vc slices. Central fibers and terminals in V2 (B) or V3 (C) division of Vc after CCI-ION in Pirt-GCaMP3 mice were
activated by capsaicin (1 mM) or 20mMKCl. Upper panels show ipsilateral V2 (B) or V3 (C) division of Vc. Lower panels show contralateral V2 (B) or V3 (C) division
of Vc. Scale bar, 50 mm.
(D–F) Time course of the amplitude of the Ca2+ transient that was evoked by capsaicin (1 mM, 10 mM) or KCl (20 mM) application at different lamina (lamina I/IIo; IIi;
III/IV) of V2 and V3 of Vc. Capsaicin was bath applied from 0 to 60 s during the time course.
(G) Ca2+ transients induced by KCl (100 mM) show no significant differences in ipsilateral and contralateral V2 and V3 of Vc after CCI-ION. The Ca2+ transient
(DF/F0) was normalized to the value imaged in baseline. Ipsi., ipsilateral; cont., contralateral. *p < 0.05; **p < 0.01; ***p < 0.001.
Data are presented as mean ± SEM.
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Mechanism of Central Terminal TRPV1 Sensitization5-HT-dependent hypersensitivity of central terminals was also
observed in neighboring uninjured V1 of the Vc and C1 spinal
cord slices (Figure S6).878 Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc.We next asked whether descending 5-HT is required for nerve
injury-induced persistent pain states. We examined mechanical
hyperalgesia 4 days after intra-RVM Tph-2 shRNA injection,
Figure 5. Descending 5-HT fromRVM IsUpregulated after CCI-ION, andNerve Injury-InducedCentral Terminal Sensitization in Vc Is Blocked
by Depletion of Descending 5-HT in the RVM
(A) Schematic diagram of descending RVM innervations into Vc. RVM (yellow) nerve fibers (red) innervate into dorsal lamina layers of Vc (blue).
(B) Vc slices from mice 14 days after CCI-ION were doubly stained with anti-GFP (for GCaMP3; green) and anti-5-HT (red) antibodies. Scale bar, 50 mm.
(C) Quantification of 5-HT levels in (B) and Figure S4B are expressed as themean density. 5-HT level in ipsilateral Vc (Ipsi.; n = 13, 48.40 ± 1.35 arbitrary unit [a.u.])
after nerve injured is significantly higher than in contralateral side (cont.; n = 8, 34.33 ± 1.55). Local gene transfer of Tph-2 shRNA into the RVM attenuated 5-HT in
Vc (n = 21, 17.18 ± 1.59) compared with that by scrambled shRNA treatment (S.; n = 10, 45.26 ± 1.27) and background (n = 21, 14.71 ± 0.87).
(D) Representative GCaMP3 imaging of Vc slices. Fourteen days after CCI-ION, central terminals in V3 of ipsilateral Vc slices, frommice, whose RVMwas treated
3 days earlier with either Tph-2 (lower panels) or scrambled shRNA (upper panels), were activated by capsaicin (1 mM) or low KCl (20 mM). Scale bar, 50 mm.
(E and F) Time course of the amplitude of the Ca2+ transient that was evoked by capsaicin (1 mM) or low KCl application at V3 in Vc. Capsaicin was bath applied
from 0 to 60 s during the time course. Ipsi./s. shRNA, ipsilateral scrambled shRNA (n = 15); cont./s. shRNA, contralateral scrambled shRNA (n = 15); ipsi./Tph
shRNA, ipsilateral Tph-2 shRNA (n = 17); cont./Tph shRNA, contralateral Tph-2 shRNA (n = 17).
(G) The effects of molecular depletion of descending 5-HT onmechanical hyperalgesia induced by CCI-ION at the V2 (injured) or V3 (uninjured) region. Behavioral
measures were done before shRNA (at 10 days after CCI-ION) and at 4 days after shRNA (14 days after CCI-ION) with intra-RVM gene transfer of Tph-2 shRNA
(n = 8) or scrambled shRNA (n = 7). *p < 0.05; **p < 0.01; ***p < 0.001.
Data are presented as mean ± SEM.
Neuron
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Mechanism of Central Terminal TRPV1 Sensitizationwhich was also 14 days after CCI-ION. Consistent with the imag-
ing results, mechanical hyperalgesia in the facial territories of
injured (V2) and uninjured (V3) nerve fibers was significantly
attenuated by the depletion of descending 5-HT from RVM
neurons (p < 0.05 in V2, p < 0.01 in V3 versus before shRNA treat-
ment) compared with the scrambled shRNA injected group (Fig-
ure 5G). Together, these data suggest that nerve injury-induced
upregulation of descending 5-HT in Vc plays an important role
in sensitizing central terminals likely through TRPV1, which con-
tributes significantly to the neuropathic pain state.
Functional 5-HT3A Receptors Are Present on Central
Terminals of Primary Sensory Neurons
The 5-HT3 receptor (5-HT3AR), the only ligand-gated cation
channel with excitatory function in the 5-HT receptor family,
has been found to mediate descending facilitation in the devel-
opment of inflammatory and neuropathic pain (Lagraize et al.,
2010; Okubo et al., 2013; Suzuki et al., 2004). 5-HT3AR is
expressed in spinal and Vc dorsal horn neurons and primary
afferent neurons as well as their central terminals (Doucet
et al., 2007). In order to determine whether functional 5-HT3ARs
are present on primary afferent central terminals, we examined
activation of 5-HT3AR on primary afferent fibers in the Vc slices
from Pirt-GCaMP3 mice. Application of the 5-HT3AR agonist
SR57227 (10 mM) induced increases in fluorescence signals in
some terminals in Vc slices from CCI-ION Pirt-GCaMP3 mice
(Figures 6A and 6B). Interestingly, the number of SR57227-sen-
sitive central terminals in the Vc from CCI-ION mice was signifi-
cantly higher than that found in the sham group (50% increase;
n = 4; p < 0.05). The specificity of SR57227 activation was deter-
mined by pretreatment with the 5-HT3AR antagonist Y25130
(10 mM), which completely abolished the Ca2+ signals evoked
by SR57227. Furthermore, SR57227 did not activate TRPV1
expressed in HEK293 cells (Figure S8C). Together, these data
suggest that functional 5-HT3ARs are present and upregulated
in the central terminals after nerve injury.
5-HT3AR Mediates the Sensitization of Central
Terminals and TRPV1
It is possible that the sensitization of central terminals we
detected after nerve injury is mediated by upregulated and spon-
taneously released 5-HT via activation of 5-HT3ARs on central
terminals. To test this possibility, we perfused 5-HT3AR antago-
nist Y25130 (10 mM) onto Vc slices from CCI-ION Pirt-GCaMP3
mice for 30 min and then stimulated the tissues with capsaicin
or low KCl. The functional blockage of 5-HT3AR significantly
attenuated capsaicin-evoked GCaMP3 signals in the ipsilateral
central terminals to a level comparable to that in the contralateral
side of Vc slices from CCI-treated mice (Figures 6C and 6D; Fig-
ures S7A, S7B, and S7D). The decrease in TRPV1 hyperactivity
caused by Y25130 occurred in all laminae of the dorsal horn in
both V2 (injured) and V3 (neighboring uninjured) subdivisions of
the Vc (Figures 6C and 6D; Figures S7A, S7B, and S7D). In addi-
tion, overall neuronal hypersensitivity of central terminals evalu-
ated by lowKCl (20mM)was also significantly suppressed by the
5-HT3AR antagonist pretreatment compared with the contralat-
eral side (Figures 6C and 6E; Figures S7A and S7C). In contrast,
pretreatment of Y25130 had no effect on response to more880 Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc.robust depolarization of central terminals induced by 100 mM
KCl (Figure S7E).
To determine whether blocking 5-HT3AR function can inhibit
neuropathic pain, the 5-HT3AR antagonist Y25130 (130 pmol/
0.5 ml) was microinjected in the ipsilateral Vc 14 days after
CCI-ION. Indeed, mechanical hyperalgesia in facial territories
innervated by injured (V2) and uninjured (V3) nerve fibers was
significantly blocked by the 5-HT3AR antagonist (p < 0.01, versus
before drug; Figure 6F). These data suggest that 5-HT3AR
activation in Vc may mediate medullary mechanisms of 5-HT-
dependent descending facilitation underlying central terminal
sensitizationof uninjurednerves responsible for neuropathic pain.
5-HT3AR Activation Facilitates Excitatory Presynaptic
Input from Primary Afferents via TRPV1 Sensitization
In order to determine the functional changes in Vc 5-HT3AR and
presynaptic TRPV1 in the regulation of Vc glutamatergic trans-
mission in trigeminal neuropathic pain after CCI-ION, we con-
ducted whole-cell patch-clamp recordings of Vc neuronal
activity in horizontal brainstem slices from adult mice. As
shown in Figures 7A–7C, spontaneousminiature excitatory post-
synaptic currents (mEPSCs) were recorded from lamina II neu-
rons identified by an evoked monosynaptic response to the
attached trigeminal nerve root. Ad/C fibers were electrically stim-
ulated (Figure S8A) from attached dorsal roots of Vc slices from
naive mice and from the ipsilateral side of Vc slices from CCI-
treated mice 14 days after injury. Application of the AMPA/
kainite receptor antagonist CNQX (10 mM) completely blocked
mEPSCs (n = 3 neurons), confirming that the recorded EPSCs
were induced by glutamatergic transmission. The frequency of
mEPSCs recorded in V3 neurons was significantly increased
14 days after CCI-ION (7.5 ± 0.44 Hz; p < 0.001), compared to
that in naive mice (2.4 ± 0.43 Hz). There was also a significant in-
crease in mEPSC amplitudes after nerve injury (40.3 ± 1.42 pA;
p < 0.05) compared to naivemice (33.6 ± 1.9 pA) (Figure 7A), sug-
gesting both enhanced presynaptic excitatory input from pri-
mary nociceptive afferents and enhanced postsynaptic neuronal
excitability. Moreover, in 9 out of 12 recorded V3 neurons from
the Vc slices of mice 14 days after CCI-ION, bath application
of the selective TRPV1 antagonist AMG9810 reversibly attenu-
ated the CCI-induced increase in mEPSCs frequency but had
no effect on the mEPSCs amplitudes (p < 0.001; Figures 7B
and 7D; Figure S8B). The same dose of AMG9810 had no effect
on EPSCs in V3 neurons from naive mice (Figure 7E). We tested
AMG9810 in HEK293 cells to ensure its specificity to TRPV1, and
it did not block 5-HT3AR activation (Figure S8D). These findings
indicate that central terminal TRPV1 sensitization contributes to
enhanced glutamatergic input from the uninjured trigeminal
nerve after CCI-ION. In addition, application of the 5-HT antago-
nist Y25130 into Vc slices also significantly blocked increased
frequency (p < 0.05, n = 7), but not amplitude of mEPSCs (Fig-
ures 7C and 7D), suggesting that presynaptic 5-HT3ARs in the
central terminals are involved in the facilitation of primary afferent
excitatory input.
Next, we recorded spontaneous EPSCs (sEPSCs) in V3 lamina
II neurons of the Vc slices from naive mice in the absence of TTX.
We observed that superfusion of 5-HT3AR agonist SR57227
(n = 7) in Vc slices significantly increased the frequency, but not
Figure 6. Functional 5-HT3Receptors Are Present onCentral Terminals of Primary Sensory Neurons andMediate the Sensitization of Central
Terminals
(A) Representative Pirt-GCaMP3 imaging of Vc slices treated with 5-HT3AR agonist by bath application. Many central terminals in Vc after nerve injury were
activated by the agonist (yellow arrowheads; n = 9). Scale bar, 20 mm.
(B) Time course of the amplitude of the Ca2+ transient that was evoked by 5-HT3AR agonist from (A).
(C) Central terminals in V3 of ipsilateral Vc slices after nerve injury were bath pretreated with either the 5-HT3AR antagonist (lower panels) or vehicle (upper panels)
for 30 min and then were activated by capsaicin (1 mM) or low KCl. Scale bar, 50 mm.
(D and E) Strong hypersensitivity of central nerve fibers and terminals in Vc after nerve injury is significantly blocked by the antagonist. Time course of the
amplitude of the Ca2+ transient that was evoked by capsaicin (1 mM) or low KCl application at V3 in Vc. Ipsi., ipsilateral (n = 15); cont., contralateral (n = 14); ipsi./
ant., ipsilateral antagonist (n = 12); cont./ant., contralateral antagonist (n = 8).
(F) Mechanical hyperalgesia was tested in V2 (injured) or V3 (uninjured) region at 14 days before and 30 min after intra-Vc 5-HT3AR antagonist (n = 8) or vehicle
(n = 6) injection in nerve injury or sham mice (n = 8, n = 6 for antagonist or vehicle, respectively). *p < 0.05; **p < 0.01; ***p < 0.001.
Data are presented as mean ± SEM.
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was partially reversed by pretreatment of AMG9810 (p < 0.05
versus SR57227 alone, n = 5) (Figure 7E). These data suggest
that presynaptic TRPV1 mediates 5-HT3AR activation-induced
enhancement of primary afferent glutamatergic release in Vc.
Finally, we examined what effect blockade of central terminal
TRPV1 function would have on CCI-induced pain behavioralresponses. Microinjection of AMG9810 into the ipsilateral Vc
significantly attenuated mechanical hyperalgesia (p < 0.05, n =
6) 14 days after CCI and had no effect on mechanical thresholds
in the sham group (n = 6) (Figure 7F). A recent report has shown
that TRPV1 is also expressed in interneurons in the spinal dorsal
horn, which contributes to the development of neuropathic pain
(Kim et al., 2012). Kim et al. (2012) also demonstrated that 5 daysNeuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 881
Figure 7. Central Terminal TRPV1 and
5-HT3AR Facilitate Synaptic Transmission
to V3 Lamina II Neurons of the Ipsilateral
Vc after CCI-ION
(A) Upper: representative traces showed mEPSCs
in one neuron of V3 division of the Vc from naive or
CCI-treated mice at 14 days. Bottom: summarized
mEPSCs frequency (left) and amplitude (right) from
V3 neurons in the Vc of different groups (n = 5–6
neurons per group). *p < 0.05; ***p < 0.001 versus
naive.
(B) Original traces show mEPSCs during baseline
control, application of selective TRPV1 antagonist
AMG9810 (10 mM, 3 min) into Vc slices, and
washout in one V3 neuron of the Vc from CCI
14 day-treated mice (right).
(C) Original traces showed mEPSCs during base-
line control and application of 5-HT3AR antagonist
Y25130 (5 mM, 3 min) in one V3 lamina II neuron of
Vc from CCI 14 day-treated mice.
(D) Normalized to the predrug treatment baseline
mEPSCs, pooled data show significant reduction
of frequencies (left) of mEPSCs in V3 neurons with
blockade of Vc TRPV1 (n = 9) or 5-HT3AR function
(n = 6) 14 days after CCI. However, there was no
change of the amplitudes of mEPSCs (right). *p <
0.05, ***p < 0.001 versus before drugs.
(E) Upper: typical traces showed sEPSCs (in
the absence of TTX) during control, application
of 5-HT3AR agonist SR57227 (10 mM, 3 min),
pretreatment of AMG9810 plus application of SR57227, and application of AMG9810 alone in one V3 neuron of the Vc slices from naivemice. Bottom: normalized
to the baseline sEPSCs, pooled data demonstrated that 10 mMSR57227-induced increase of the frequency (the left), but not of the amplitude (the right) of sEPSCs
in seven neurons from the Vc slices of naive mice. Pretreatment of AMG9810 attenuated SR57227-induced increase of the frequency of sEPSCs without effects
on baseline control. ***p < 0.001, versus baseline control; #p < 0.05 versus SR57227 alone.
(F) Effects of intra-Vc injection of AMG9810 (5 pmol/0.5 ml) on CCI-induced mechanical hyperalgesia 14 days after nerve injury (n = 6–8 mice per groups).
**p < 0.01, versus baseline; #, p < 0.05 versus before drug treatment.
Data are presented as mean ± SEM.
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iferatoxin (RTX), TRPV1+ neurons in theDRG, but not in the spinal
cord, were selectively ablated. We i.p. injected RTX into CCI-ION
mice in order to distinguish the action of TRPV1 at the central
terminals of primary sensory neurons and dorsal horn neurons.
However, we did both GCaMP imaging and pain behavioral
testing 1 day after RTX treatment, instead of 5 days after treat-
ment as done by Kim et al. (2012). The reason for this modifica-
tion was that we wanted to use RTX to silence presynaptic
TRPV1 channels, but not ablate the TRPV1+ primary sensory
neurons. Ablation of TRPV1+ neurons, as seen 5 days after
RTX injection, would prevent us from analyzing the hyperactivity
of presynaptic TRPV1 and their contribution to mechanical
hyperalgesia. Capsaicin and low KCl-evoked neuronal hyperac-
tivity of the Vc central terminals from RTX treated animals (i.e.,
14 days after CCI-ION and 1 day after RTX injection) was signif-
icantly decreased when compared to vehicle-treated CCI-ION
mice (Figures 8A–8C). However, high KCl-induced depolariza-
tion of the central terminals from RTX and vehicle-treated Vc
slices were comparable (Figure 8D), indicating the central termi-
nals are still functional after RTX treatment. Strikingly, after RTX
treatment (n = 7), CCI-ION mice exhibited a significant reduction
in mechanical hypersensitivity compared with CCI-ION mice
treated with vehicle (n = 8) (Figure 8E). The selective reduction882 Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc.of TRPV1 mRNA level in the TG was confirmed at 5 days
after RTX injection by quantitative real-time PCR (Figure 8F).
However, the expression of TRPV1 by intrinsic neurons in the
Vc was not affected by the RTX treatment even after 5 days.
This indicated that systemic RTX did not silence TRPV1 in
the dorsal horn neurons. These data suggest that central termi-
nal TRPV1 is essential for nerve injury-induced mechanical
hypersensitivity.
DISCUSSION
Imaging neuronal activity in primary sensory neurons from tissue
explants and slices has been a challenge given that their nerve
endings and cell bodies are densely surrounded by other cells
and therefore are difficult to selectively load with Ca2+-sensitive
chemical dyes. By specifically expressing a genetically encoded
Ca2+-sensitive indicator in almost all DRG and TG neurons in
Pirt-GCaMP3 mice, we successfully detected activation of pri-
mary sensory neurons in the trigeminal system at peripheral
and central terminals as well as in their cell bodies, in tissue
explant, and in slice preparations. The advantages of this
method are manifold: simple tissue preparation and imaging
procedures, excellent spatial resolution, sensitive, high-effi-
ciency simultaneous imaging of multiple neurons, preservation
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Mechanism of Central Terminal TRPV1 Sensitizationof somatotopic organization, and stable expression of GCaMP3
after nerve injury.
Previous immunostaining data have shown that nerve injury
causes large diameter neurons that normally do not express
TRPV1 to become TRPV1 positive (Hudson et al., 2001). Consis-
tent with these findings, our imaging data demonstrate that
following nerve injury, the somata of many large diameter neu-
rons in the injured V2 are activated by capsaicin. Although
some of these may represent C or Ad-nociceptors, others are
likely to include large-diameter low-threshold Ab mechanore-
ceptors; this corresponds with our observation of increased
capsaicin sensitivity in projections to lamina III and IV of the
Vc, which normally receive only large-diameter nonnociceptive
input (Devor, 2009; Li et al., 2011). These findings support the
idea of a phenotypic switch in injured neurons that formerly de-
tected only innocuous stimuli to a state involving nociceptor-like
characteristics (Costigan et al., 2009). Although a similar gain
of capsaicin sensitivity was not evident from imaging of the
uninjured V3 somata, examination of the uninjured afferents
innervating lamina III and IV of the Vc showed acquired capsa-
icin sensitivity (comparing Figures 4D and 4E with Figures 3D
and 3E). Furthermore, responsiveness to low KCl was also
augmented in the central terminals of both injured and uninjured
afferents, indicating overall neuronal sensitization. These data
suggest that sensitization occurs in both injured and uninjured
afferents and that sensitization in the central terminals of unin-
jured neurons is more evident than in their cell bodies.
Recent studies from our and other groups have shown that de-
scending 5-HT from the RVM facilitates persistent pain (Okubo
et al., 2013; Wei et al., 2010). However, the underlying mecha-
nisms are far from clear, because many 5-HT receptor subtypes
are present on both central terminals of primary sensory neurons
and intrinsic dorsal horn neurons. Therefore, it is difficult to
determine onto which neuronal population and nerve fibers
within the dorsal horn, 5-HT exerts a facilitating effect. In fact,
most studies have focused on the effect of descending modula-
tion on intrinsic dorsal horn neurons. We identified a mechanism
in which supraspinal descending 5-HT sensitizes the central ter-
minals of primary sensory neurons via a cascade that succes-
sively involves presynaptic 5-HT3AR and TRPV1 to promote
chronic neuropathic pain (Figure 8G). After nerve injury, the upre-
gulation of descending 5-HT and subsequent engagement of
primary afferent central terminal 5HT3AR activation are likely
drivers of central sensitization in addition to postsynaptic effects
on dorsal horn neurons. Our study demonstrates that central ter-
minal sensitization driven by supraspinal descending facilitation
contributes to spinal sensitization and spreading pain hypersen-
sitivity from injured (V2) to surrounding uninjured (V3) territories
during some persistent or chronic pain states.
Clinical studies have demonstrated an analgesic effect of
selective 5-HT3R antagonists in patients with neuropathic pain
(McCleane et al., 2003). Our findings suggest approaches for
treatments with 5-HT3R antagonists in chronic pain conditions
in which active descending facilitation possibly maintains central
terminal sensitization. The development of agents that suppress
5-HT/5-HT3R-dependent and TRPV1-involved central terminal
sensitization may be necessary to achieve favorable treatment
effects.Previous studies have shown that TRPV1 activity can be
potentiated by 5-HT via both metabotropic and ionotropic
5-HT receptors, such as 5-HT2, 3, 4, and 7 receptors (Loyd
et al., 2011; Ohta et al., 2006; Sugiuar et al., 2004). Multiple
signaling pathways, including protein kinase A and C (PKA and
PKC), have been implicated in the potentiation. It is conceivable
that other 5-HT receptors other than 5-HT3AR are involved in the
central terminal TRPV1 sensitization. A candidate molecular link
between 5-HT3AR and its downstream effector TRPV1 is PKC
because it can be activated by 5-HT3AR and phosphorylation
of TRPV1 by PKC leads to potentiation of TRPV1 activity (Khan
and Hichami, 1999; Vay et al., 2012). Previous studies have
shown that the sensitization of TRPV1 resulted in larger mem-
brane depolarizations that led to a lower threshold of neuronal
activation and increased overall excitability (Neelands et al.,
2008; Zhang et al., 2011). Low KCl, which induced weak excita-
tion of naive central terminals in contralateral Vc, could strongly
activate the central terminals in ipsilateral Vc as indicated by in-
crease in Ca2+ signals. The stronger activation by low KCl is due
to sensitization of TRPV1 in the ipsilateral central terminals. It has
also been previously reported that TRPV1 activation in cranial
visceral afferent terminals allows calcium entry into the termi-
nals; this entry increases the rate of glutamate vesicle fusion
and release (Shoudai et al., 2010). So while TRPV1 acts as a mo-
lecular sensor for noxious heat and capsaicin in peripheral nerve
terminals, its hyperactivity in central terminals also contributes to
overall central terminal sensitization during chronic pain states.
Although TRPV1 is not a mechanotransducer per se, blocking
its activity centrally inhibited mechanical hyperalgesia. There-
fore, our current study directly demonstrates a role for TRPV1
and its facilitation in the central terminals and a strategy to treat
chronic pain. It is possible that TRPV1-independent mechanisms
also contribute to the neuronal hypersensitivity of the central
terminals of primary sensory neurons because 5-HT3AR may
modulate other downstream channels besides TRPV1.
Our current study has been focused on a CNS mechanism of
central terminal sensitization by 5-HT-dependent descending
facilitation after nerve injury. Several possiblemechanismsmight
contribute to the sensitization of uninjured peripheral terminals in
the skin. It appears unlikely that sensitization of terminals in the
V3 ear skin is due to a direct interaction between the terminals
of injured nerves in the V2 skin and those of uninjured nerves in
the V3 ear skin, because the distance between the two receptive
fields examined is large. Given that the most distal site of close
contact between the V2 and V3 neurons is within the trigeminal
ganglion, a more likely mechanism is that the somata of injured
nerves, their central axons, and/or the intraganglionic domains
of their peripheral axons secretemolecules, suchasnervegrowth
factor, to sensitize neighboring uninjured nerves (Shinoda et al.,
2011). By retrograde and anterograde trafficking of channels, re-
ceptors, and other molecules, nerve endings in the skin and in
the spinal cord/Vc, respectively, would then become hypersensi-
tive to painful stimuli. Future experiments combining GCaMP
imaging with pharmacological, electrophysiological, and genetic
approacheswill be necessary todefinitively address thesemech-
anistic possibilities. Regardless, our current study directly dem-
onstrates a role for TRPV1 and its facilitation in primary afferent
central terminals and a strategy to treat chronic pain.Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 883
Figure 8. Selective Silencing of TRPV1 in the Central Terminals of Primary Sensory Neurons Blocks Neuronal Hypersensitivity of the Central
Terminals and Neuropathic Pain
(A–D) Vc slices from CCI-ION treated Pirt-GCaMP3mice that were i.p. injected with either RTX (n = 17) or vehicle (n = 14) were imaged in response to capsaicin
and KCl. The time course of the amplitude of the Ca2+ transient that was evoked by capsaicin (1 mM, 10 mM) or KCl (20 mM) application at different lamina (lamina
I/IIo; lamina IIi; lamina III/IV) of V2 and V3 of Vc is shown. Capsaicin was bath applied from 0 to 60 s during the time course. Capsaicin-evoked responses were
completely gone in the Vc from RTX-treated mice (A) and (B). (D) Ca2+ transients induced by high KCl (100 mM) show no significant differences in the ipsilateral
(legend continued on next page)
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Animals
Pirt-GCaMP3mice were generated by targeted homologous recombination to
replace the entire coding region of the Pirt gene with the GCaMP3 sequence
fused with a neomycin resistance gene sequence and put in-frame with
the Pirt promoter. Pirt-GCaMP3 heterozygotes were used in all experiments.
Details are available in the Supplemental Experimental Procedures.
Animal Model
All experiments were performed in accordancewith the protocols approved by
the Animal Care andUse Committee at the Johns Hopkins University School of
Medicine and University of Maryland Dental School. Themice used in the tests
were backcrossed to C57Bl/6 mice for at least six generations and were 1- to
2-month-oldmales. To produce the CCI-IONmodel, chronic constriction injury
was performed using loose ligatures of unilateral ION via an intraoral approach.
Mice were anesthetized with pentobarbital sodium (50mg/kg i.p.), and the ION
was loosely tied with two-four chromic gut (4.0) ligatures through an incision
in the palatal-buccal mucosa. The incision was closed using tissue glue. The
sham-operated mice received only a unilateral nerve exposure without
ligatures.
Behavioral Test
Behavioral tests were conducted by experimenters blind to conditions. To
reduce any effects of restraint, either by hand (Seino et al., 2009) or grasping
the tail (Krzyzanowska et al., 2011), on behavioral assessment of the mice,
we adopted a less stressful method (Aita et al., 2010) and developed
a more precise probing technique to test mechanical hypersensitivity in V2
and V3 skin. Mice were placed in a box (3 3 3 3 4 in) with the top, bottom,
and four walls made of black wire mesh and were allowed to freely move.
Von Frey filaments were applied to the skin near the center of the vibrissa
pad within the infraorbital territory (V2) and the skin within the mandibular
nerve territory (V3). A brisk or active withdrawal of the head from the probing
filament was defined as a response. See the Supplemental Experimental
Procedures for details.
Brainstem Microinjection and Gene Transfer
As previously described (Wei et al., 2010), Suresilencing shRNA plasmids for
Tph-2 (TCAACATGCTCCATATTGAAT) and scrambled control (ggaatctcattcg
atgcatac) (0.5 mg/0.5 ml) was injected into the RVM. Details are available in
the Supplemental Experimental Procedures.
RTX Treatment
Eleven days after ION-CCI, mice were intraperitoneally injected with RTX or
vehicle (dissolved in a mixture of 10% Tween 80 and 10% ethanol in normal
saline) as a single dose in two injections of 50 mg/kg and 150 mg/kg on days
1 and 2, consecutively. The mice were injected under 3% isoflurane inhalation
anesthesia andmaintained anesthesia for 2–3 hr after RTX or vehicle. Mechan-
ical thresholds and GCaMP3 imaging were performed 1 day after the second
RTX injection. The mRNA levels of TRPV1 in the TG and Vc from CCI-ION
mice at 5 days after RTX or vehicle injection were determined by quantitative
RT-PCR using TRPV1 specific primers: 50 ATCATCAACGAGGACCCAGG 30
and 50 TGCTATGCCTATCTCGAGTGC 30.and contralateral V2 and V3 of Vc after CCI-ION in Pirt-GCaMP3mice. The Ca2+ tr
cont., contralateral.
(E) Effects of i.p. injection of RTX on CCI-induced mechanical hyperalgesia 14 d
(F) Quantitative real-time PCR was performed on total RNAs isolated from TG and
(n = 4 per group). TRPV1 levels were normalized by b-actin in each sample. *p <
(G) Schematic illustration of the proposedmechanism. CCI-ION-induced hyperact
signal input leads to dorsal horn V2 neuron activation in the Vc; neuronal activation
then descend to the RVM. Enhanced 5-HT release from the RVM leads to enhanc
primary afferents in the V2 and V3 subdivision of the ipsilateral Vc, resulting in ce
behavioral hypersensitivity to uninjured nearby facial skin.
Data are presented as mean ± SEM.Pirt-GCaMP3 Ca2+ Imaging
Ten to seventeen days after CCI-ION, 2-month-old mice were sacrificed by
CO2 asphyxiation. Ear skin, TG explants, and Vc slice was acutely isolated
from Pirt-GCaMP3 mice and used to image and determine Ca2+ transients.
All experiments were performed at room temperature (25C), in a chamber
with stimuli applied by bath application. GFP signals from Pirt-GCaMP3
mice were measured to see Ca2+ transients using green emitted light. Single
photon Ca2+ imaging was performed with a 700 Zeiss confocal microscope,
using the 488 nm line of a solid state laser for excitation of Pirt-GCaMP3
and a 488 nm laser main dichroic beam splitter (MBS) and a 505–555 nm var-
iable secondary dichroic mirror (VSD) to detect the emission of green fluores-
cence. Details are available in the Supplemental Experimental Procedures.
Whole-Cell Patch-Clamp Recording in Vc Slices
The brain stem was dissected and horizontally sliced at a thickness of 400 mm.
Slices were kept in an 50 ml glass beaker containing carbogenated protective
aCSF at 33C. After at least a 1 hr recovery, the brainstem slice was transferred
into a recording chamber and was continuously perfused (10–15 ml/min) with
oxygenated Krebs’ solution (composition in mM: NaCl 126, NaHCO3 26,
glucose 10, KCl 2.5, CaCl2 2, MgCl2 1.2, and NaH2PO4 1.25) at room temper-
ature. sEPSCs or mEPSCs were recorded continuously at a holding potential
of70 mV in the absence or presence of 0.5 mM tetrodotoxin, respectively. To
block inhibitory transmission, 1 mM strychnine sulfate and 10 mM bicuculline
methiodide were included in the superfusate in all the experiments. Blind
whole-cell voltage-clamp recordings were performed with series resistance
compensation using an EPC 10 amplifier. See the Supplemental Experimental
Procedures for details.
Analysis
Group data are expressed as mean ± SEM. Unless otherwise noted, unpaired
Student’s t test was used to determine significance in statistical comparisons,
and differences were considered significant at p < 0.05. Animal behavior data
were analyzed with two-way ANOVA test. Patch-clamp recording data were
analyzed with Mini Analysis (v. 6.0.3) (Synaptosoft). The statistical significance
was set at p < 0.05 using Student’s t test or Kolmogorov-Smirnov (K-S) test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and eight movies and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2013.12.011.
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ntral terminal sensitization of injury and uninjured nerve fibers and a spread of
Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 885
Neuron
Mechanism of Central Terminal TRPV1 SensitizationInstitute. Dr. Caterina is an inventor on a patent on the use of products related
to TRPV1, which is licensed through the University of California, San Francisco
and Merck, and may be entitled to royalties related to these products. He is on
the Scientific Advisory Board for Hydra Biosciences, which develops products
related to TRP channels. These conflicts are being managed by the Johns
Hopkins Office on Policy Coordination.
Accepted: December 2, 2013
Published: January 23, 2014
REFERENCES
Aita, M., Byers, M.R., Chavkin, C., and Xu, M. (2010). Trigeminal injury causes
kappa opioid-dependent allodynic, glial and immune cell responses in mice.
Mol. Pain 6, 8.
Basbaum, A.I., Bautista, D.M., Scherrer, G., and Julius, D. (2009). Cellular and
molecular mechanisms of pain. Cell 139, 267–284.
Bhave, G., Zhu, W., Wang, H., Brasier, D.J., Oxford, G.S., and Gereau, R.W.,
4th. (2002). cAMP-dependent protein kinase regulates desensitization of the
capsaicin receptor (VR1) by direct phosphorylation. Neuron 35, 721–731.
Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D.,
and Julius, D. (1997). The capsaicin receptor: a heat-activated ion channel in
the pain pathway. Nature 389, 816–824.
Caterina, M.J., Leffler, A., Malmberg, A.B., Martin, W.J., Trafton, J., Petersen-
Zeitz, K.R., Koltzenburg, M., Basbaum, A.I., and Julius, D. (2000). Impaired
nociception and pain sensation in mice lacking the capsaicin receptor.
Science 288, 306–313.
Costigan, M., Scholz, J., andWoolf, C.J. (2009). Neuropathic pain: a maladap-
tive response of the nervous system to damage. Annu. Rev. Neurosci. 32,
1–32.
Devor, M. (2009). Ectopic discharge in Abeta afferents as a source of neuro-
pathic pain. Exp. Brain Res. 196, 115–128.
Doucet, E., Latre´molie`re, A., Darmon, M., Hamon, M., and Emerit, M.B. (2007).
Immunolabelling of the 5-HT 3B receptor subunit in the central and peripheral
nervous systems in rodents. Eur. J. Neurosci. 26, 355–366.
Gregus, A.M., Doolen, S., Dumlao, D.S., Buczynski, M.W., Takasusuki, T.,
Fitzsimmons, B.L., Hua, X.Y., Taylor, B.K., Dennis, E.A., and Yaksh, T.L.
(2012). Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflamma-
tory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc. Natl.
Acad. Sci. USA 109, 6721–6726.
Guo, A., Vulchanova, L., Wang, J., Li, X., and Elde, R. (1999).
Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship
to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J.
Neurosci. 11, 946–958.
Hudson, L.J., Bevan, S., Wotherspoon, G., Gentry, C., Fox, A., and Winter, J.
(2001). VR1 protein expression increases in undamaged DRG neurons after
partial nerve injury. Eur. J. Neurosci. 13, 2105–2114.
Invernizzi, R.W. (2007). Role of TPH-2 in brain function: news from behavioral
and pharmacologic studies. J. Neurosci. Res. 85, 3030–3035.
Khan, N.A., and Hichami, A. (1999). Ionotrophic 5-hydroxytryptamine type 3
receptor activates the protein kinase C-dependent phospholipase D pathway
in human T-cells. Biochem. J. 344, 199–204.
Kim, A.Y., Tang, Z., Liu, Q., Patel, K.N., Maag, D., Geng, Y., and Dong, X.
(2008). Pirt, a phosphoinositide-binding protein, functions as a regulatory
subunit of TRPV1. Cell 133, 475–485.
Kim, Y.H., Back, S.K., Davies, A.J., Jeong, H., Jo, H.J., Chung, G., Na, H.S.,
Bae, Y.C., Kim, S.J., Kim, J.S., et al. (2012). TRPV1 in GABAergic interneurons
mediates neuropathic mechanical allodynia and disinhibition of the nocicep-
tive circuitry in the spinal cord. Neuron 74, 640–647.
Klein, B.G., Renehan, W.E., Jacquin, M.F., and Rhoades, R.W. (1988).
Anatomical consequences of neonatal infraorbital nerve transection upon
the trigeminal ganglion and vibrissa follicle nerves in the adult rat. J. Comp.
Neurol. 268, 469–488.886 Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc.Krzyzanowska, A., Pittolo, S., Cabrerizo, M., Sa´nchez-Lo´pez, J., Krishnasamy,
S., Venero, C., and Avendan˜o, C. (2011). Assessing nociceptive sensitivity in
mouse models of inflammatory and neuropathic trigeminal pain. J. Neurosci.
Methods 201, 46–54.
Lagraize, S.C., Guo, W., Yang, K., Wei, F., Ren, K., and Dubner, R. (2010).
Spinal cord mechanisms mediating behavioral hyperalgesia induced by
neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla.
Neuroscience 171, 1341–1356.
LaMotte, C.C., and de Lanerolle, N.C. (1983). Ultrastructure of chemically
defined neuron systems in the dorsal horn of the monkey. III. Serotonin immu-
noreactivity. Brain Res. 274, 65–77.
Li, L., Rutlin, M., Abraira, V.E., Cassidy, C., Kus, L., Gong, S., Jankowski, M.P.,
Luo, W., Heintz, N., Koerber, H.R., et al. (2011). The functional organization of
cutaneous low-threshold mechanosensory neurons. Cell 147, 1615–1627.
Loyd, D.R., Weiss, G., Henry, M.A., and Hargreaves, K.M. (2011). Serotonin in-
creases the functional activity of capsaicin-sensitive rat trigeminal nociceptors
via peripheral serotonin receptors. Pain 152, 2267–2276.
Lukacs, V., Thyagarajan, B., Varnai, P., Balla, A., Balla, T., and Rohacs, T.
(2007). Dual regulation of TRPV1 by phosphoinositides. J. Neurosci. 27,
7070–7080.
Mason, P. (2001). Contributions of the medullary raphe and ventromedial
reticular region to pain modulation and other homeostatic functions. Annu.
Rev. Neurosci. 24, 737–777.
McCleane, G.J., Suzuki, R., and Dickenson, A.H. (2003). Does a single intrave-
nous injection of the 5HT3 receptor antagonist ondansetron have an analgesic
effect in neuropathic pain? A double-blinded, placebo-controlled cross-over
study. Anesth. Analg. 97, 1474–1478.
Mosconi, T., Woolsey, T.A., and Jacquin, M.F. (2010). Passive vs. active
touch-induced activity in the developing whisker pathway. Eur. J. Neurosci.
32, 1354–1363.
Nakajima, A., Tsuboi, Y., Suzuki, I., Honda, K., Shinoda, M., Kondo, M.,
Matsuura, S., Shibuta, K., Yasuda, M., Shimizu, N., and Iwata, K. (2011).
PKCgamma in Vc and C1/C2 is involved in trigeminal neuropathic pain.
J. Dent. Res. 90, 777–781.
Neelands, T.R., Jarvis, M.F., Faltynek, C.R., and Surowy, C.S. (2008). Elevated
temperatures alter TRPV1 agonist-evoked excitability of dorsal root ganglion
neurons. Inflamm Res. 57, 404–409.
Neubert, J.K., Mannes, A.J., Keller, J., Wexel, M., Iadarola, M.J., and Caudle,
R.M. (2005). Peripheral targeting of the trigeminal ganglion via the infraorbital
foramen as a therapeutic strategy. Brain Res. Brain Res. Protoc. 15, 119–126.
Ohta, T., Ikemi, Y., Murakami,M., Imagawa, T., Otsuguro, K., and Ito, S. (2006).
Potentiation of transient receptor potential V1 functions by the activation of
metabotropic 5-HT receptors in rat primary sensory neurons. J. Physiol. 576,
809–822.
Okubo, M., Castro, A., Guo, W., Zou, S., Ren, K., Wei, F., Keller, A., and
Dubner, R. (2013). Transition to persistent orofacial pain after nerve injury
involves supraspinal serotonin mechanisms. J. Neurosci. 33, 5152–5161.
Ren, K., and Dubner, R. (2002). Descending modulation in persistent pain: an
update. Pain 100, 1–6.
Rexed, B. (1952). The cytoarchitectonic organization of the spinal cord in the
cat. J. Comp. Neurol. 96, 414–495.
Ringkamp, M., andMeyer, R.A. (2005). Injured versus uninjured afferents:Who
is to blame for neuropathic pain? Anesthesiology 103, 221–223.
Seino, H., Seo, K., Maeda, T., and Someya, G. (2009). Behavioural and
histological observations of sensory impairment caused by tight ligation of
the trigeminal nerve in mice. J. Neurosci. Methods 181, 67–72.
Shinoda, M., Asano, M., Omagari, D., Honda, K., Hitomi, S., Katagiri, A., and
Iwata, K. (2011). Nerve growth factor contribution via transient receptor
potential vanilloid 1 to ectopic orofacial pain. J. Neurosci. 31, 7145–7155.
Shoudai, K., Peters, J.H., McDougall, S.J., Fawley, J.A., and Andresen, M.C.
(2010). Thermally active TRPV1 tonically drives central spontaneous glutamate
release. J. Neurosci. 30, 14470–14475.
Neuron
Mechanism of Central Terminal TRPV1 SensitizationSikand, P., and Premkumar, L.S. (2007). Potentiation of glutamatergic synaptic
transmission by protein kinase C-mediated sensitization of TRPV1 at the first
sensory synapse. J. Physiol. 581, 631–647.
Sugiuar, T., Bielefeldt, K., and Gebhart, G.F. (2004). TRPV1 function in mouse
colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine
receptor activation. J. Neurosci. 24, 9521–9530.
Suzuki, R., Rahman, W., Hunt, S.P., and Dickenson, A.H. (2004). Descending
facilitatory control of mechanically evoked responses is enhanced in deep
dorsal horn neurones following peripheral nerve injury. Brain Res. 1019, 68–76.
Tian, L., Hires, S.A., Mao, T., Huber, D., Chiappe, M.E., Chalasani, S.H.,
Petreanu, L., Akerboom, J., McKinney, S.A., Schreiter, E.R., et al. (2009).
Imaging neural activity in worms, flies andmicewith improvedGCaMP calcium
indicators. Nat. Methods 6, 875–881.
Tognetto, M., Amadesi, S., Harrison, S., Creminon, C., Trevisani, M., Carreras,
M., Matera, M., Geppetti, P., and Bianchi, A. (2001). Anandamide excites cen-
tral terminals of dorsal root ganglion neurons via vanilloid receptor-1 activa-
tion. J. Neurosci. 21, 1104–1109.
Treede, R.D., Meyer, R.A., Raja, S.N., and Campbell, J.N. (1992). Peripheral
and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 38,
397–421.Vay, L., Gu, C., and McNaughton, P.A. (2012). The thermo-TRP ion channel
family: properties and therapeutic implications. Br. J. Pharmacol. 165,
787–801.
Wei, F., Guo, W., Zou, S., Ren, K., and Dubner, R. (2008). ). Supraspinal glial-
neuronal interactions contribute to descending pain facilitation. J. Neurosci.
28, 10482–10495.
Wei, F., Dubner, R., Zou, S., Ren, K., Bai, G., Wei, D., and Guo, W. (2010).
Molecular depletion of descending serotonin unmasks its novel facilitatory
role in the development of persistent pain. J. Neurosci. 30, 8624–8636.
Yang, K., Kumamoto, E., Furue, H., and Yoshimura, M. (1998). Capsaicin
facilitates excitatory but not inhibitory synaptic transmission in substantia
gelatinosa of the rat spinal cord. Neurosci. Lett. 255, 135–138.
Zhang, X., Huang, J., and McNaughton, P.A. (2005). NGF rapidly increases
membrane expression of TRPV1 heat-gated ion channels. EMBO J. 24,
4211–4223.
Zhang, X., Li, L., and McNaughton, P.A. (2008). Proinflammatory mediators
modulate the heat-activated ion channel TRPV1 via the scaffolding protein
AKAP79/150. Neuron 59, 450–461.
Zhang, X.F., Han, P., Neelands, T.R., McGaraughty, S., Honore, P., Surowy,
C.S., and Zhang, D. (2011). Coexpression and activation of TRPV1 suppress
the activity of the KCNQ2/3 channel. J. Gen. Physiol. 138, 341–352.Neuron 81, 873–887, February 19, 2014 ª2014 Elsevier Inc. 887
